| __timestamp | ACADIA Pharmaceuticals Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 22622695 |
| Thursday, January 1, 2015 | 76369000 | 24863028 |
| Friday, January 1, 2016 | 4406000 | 21351001 |
| Sunday, January 1, 2017 | 13060000 | 53837297 |
| Monday, January 1, 2018 | 18330000 | 16080096 |
| Tuesday, January 1, 2019 | 19598000 | 18525736 |
| Wednesday, January 1, 2020 | 20550000 | 2024000 |
| Friday, January 1, 2021 | 19141000 | 2548000 |
| Saturday, January 1, 2022 | 10166000 | 61556000 |
| Sunday, January 1, 2023 | 45731000 | 188157000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between Telix Pharmaceuticals Limited and ACADIA Pharmaceuticals Inc. from 2014 to 2023. Over this period, Telix Pharmaceuticals demonstrated a remarkable increase in cost efficiency, with a staggering 732% rise in their cost of revenue from 2014 to 2023. In contrast, ACADIA Pharmaceuticals experienced a more modest 24% increase over the same period.
The data reveals that while both companies faced fluctuations, Telix's cost of revenue peaked in 2023, reaching nearly 188 million, a significant leap from its 2014 figure. Meanwhile, ACADIA's cost of revenue peaked in 2015 but saw a decline in subsequent years, only to rise again in 2023. This trend highlights the dynamic nature of the pharmaceutical industry and the importance of strategic financial management.
Cost Insights: Breaking Down Sanofi and Telix Pharmaceuticals Limited's Expenses
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Exelixis, Inc. and Telix Pharmaceuticals Limited
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Grifols, S.A. vs ACADIA Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs Evotec SE